PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for May 29, 2007 Subscribe to this News Feed    Subscribe to this Podcast Feed
 

Blocked Legislation Ensures There is No Relief in Sight from Rising Drug Prices, Says DoctorSolve

Big Pharma succeeds once again in blocking drug importation and preventing negotiation of lower drug prices.

Vancouver, B.C. (PRWEB) May 29, 2007 -- Recently, thanks to the financial clout of Big Pharma, American consumers were dealt two major blows to their pocket books.

In April, Republican Senate leaders blocked a bill that would allow Medicare to negotiate for lower prices for the drugs required by seniors under the Medicare Part D program. In May, adding insult to injury, Americans were betrayed again when a Republican amendment upheld the law blocking the importation of prescription drugs from other countries.

"Americans are forced to pay the highest prices for medications in the world," says Dr. Paul Zickler of DoctorSolve Healthcare Services (www.doctorsolve.com). "Yet their politicians continually sabotage any efforts to assuage this cruel fact."

Why? Because there is more money in fleecing Americans than looking after their best interests. In 2006 alone, the drug industry spent $172 million on lobbying efforts. That's the kind of money that can make a break a political party's chances for re-election.

Meanwhile, the plan that was intended to bring pharmaceutical prices down is doing quite the opposite. According to a report, released by the consumer health organization, Families USA, the median Part D drug price increase was 9.2 percent - almost four times the latest inflation rate of 2.4 percent, and almost three times the increase in this year's cost-of-living adjustment in Social Security (3.3 percent).

"The report shows that the cost of drugs most commonly used by seniors skyrocketed last year," says Zickler. "For example, a year's supply of Lipitor, a cholesterol-lowering drug, went up 9.2 percent. Fosamax, used to treat osteoporosis, rose by 10.7 percent. The elderly are forced to pay unfair prices, while Big Pharma soaks up the profits."

"American seniors are being forced to seek out affordable alternatives to get their meds because they cannot afford the inflated prices of US drugs," says Zickler. "They come to us because they can save 30 - 70 percent, and they know we go to great lengths to protect their safety through our Safety Service Guarantee.

"Unlike American politicians and the drug companies, we are DoctorSolve Healthcare Services put the interest of American seniors first."

DoctorSolve, a Canadian Internet-based pharmacy intermediary (license #BC Q37), offers lower-cost, long-term prescriptions. A professionally registered pharmacist fills all prescriptions. A certified member of the Canadian International Pharmacy Association, DoctorSolve is ranked as one of the best online pharmacies by PharmacyChecker.com. DoctorSolve has filled more than 550,000 U.S. prescriptions.

For more information, call 1-866-732-0305 or visit http://www.doctorsolve.com

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/U2luZy1Db3VwLUNyYXMtRW1wdC1UaGlyLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
Download Podcast MP3
Download Podcast iTunes
Download Podcast OGG
BlogThis
ShareThis
CONTACT INFORMATION
Terry Johnson
Doctorsolve Health Services
1-866-732-0305
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.